ABSTRACT Background: We previously showed that microbial metabolism in the gut influences the composition of bioactive fatty acids in host adipose tissue. Objective: This study compared the effect of dietary supplementation for 8 wk with human-derived Bifidobacterium breve strains on fat distribution and composition and the composition of the gut microbiota in mice. Methods: C57BL/6 mice (n = 8 per group) received B. breve DPC 6330 or B. breve NCIMB 702258 (10 9 microorganisms) daily for 8 wk or no supplement (controls). Tissue fatty acid composition was assessed by gas-liquid chromatography while 16S rRNA pyrosequencing was used to investigate microbiota composition. Results: Visceral fat mass and brain stearic acid, arachidonic acid, and DHA were higher in mice supplemented with B. breve NCIMB 702258 than in mice in the other 2 groups (P , 0.05). In addition, both B. breve DPC 6330 and B. breve NCIMB 702258 supplementation resulted in higher propionate concentrations in the cecum than did no supplementation (P , 0.05). Compositional sequencing of the gut microbiota showed a tendency for greater proportions of Clostridiaceae (25%, 12%, and 18%; P = 0.08) and lower proportions of Eubacteriaceae (3%, 12%, and 13%; P = 0.06) in mice supplemented with B. breve DPC 6330 than in mice supplemented with B. breve NCIMB 702258 and unsupplemented controls, respectively. Conclusion: The response of fatty acid metabolism to administration of bifidobacteria is strain-dependent, and strain-strain differences are important factors that influence modulation of the gut microbial community by ingested microorganisms.
INTRODUCTION
The human gut microbiota comprises trillions of microorganisms, reaching cell numbers that outnumber that of host cells, and contains 100-fold more genes than the human genome (1) . The collective genome of these microorganisms (the metagenome) contributes to a broad range of metabolic and biochemical functions that the host could not otherwise perform (2) . Recent research has shown an interaction between the gut microbiota and host metabolism, energy utilization, and fat storage, which suggests that intestinal microbes play a direct role in the development of obesity (2) (3) (4) (5) . Metagenomic analyses have also shown that the cecal microbiota of ob/ob mice and obese individuals are more efficient at energy extraction from the diet and at producing short-chain fatty acids (SCFAs) 4 than are those of normal phenotype (3, 6) . These SCFAs can then be used for de novo synthesis of lipids and glucose (7), thus providing an additional source of energy for the host. Whereas some studies of bacterial communities in the gut microbiota in both mouse models and in humans, using compositional sequencing, have shown an increase in the ratio of Firmicutes to Bacteroidetes in obese subjects (2, 8) , the identity of the microbial populations that are associated with obesity continues to be the subject of much debate, with others reporting a decreased Firmicutes to Bacteroidetes ratio in overweight and obese individuals (6, 9) . Another study reported no link between the proportion of Firmicutes and Bacteroidetes and human obesity (10) . Whether alterations in the microbiota are a cause or consequence of obesity is furthermore controversial, and the role of the gut microbiota in fat metabolism and obesity is more complex than first considered (9) (10) (11) . Thus, the interrelation between the gut microbial composition, diet, and host adiposity has to be further investigated. Knowledge of the interactions between energy intake and specific microbial populations, and their influence on body weight, is limited to small-scale clinical trials (2) . Among the gastrointestinal bacteria, Bifidobacterium is an important commensal group, accounting for an estimated 3% of the intestinal microbiota from an average adult (12, 13) . Because of their well-documented beneficial health effects (14) , bifidobacteria have attracted significant interest for probiotic applications in pharmaceutical and dairy products. In relation to host energy metabolism, higher numbers of bifidobacteria have been documented in normal-weight adults and adolescents than in their overweight counterparts (15, 16) . However, some recent studies suggest that the role of bifidobacteria in weight management may be species-specific. Thus, Santacruz et al (17) reported that weight loss was associated with a reduction in the numbers of Bifidobacterium breve and Bifidobacterium bifidum and an increase in the numbers of Bifidobacterium catenulatum.
A promising mechanism by which the manipulation of the gut microbiota can affect host metabolism and fat storage is the modulation of fatty acid composition of host cellular membranes. We previously showed that dietary supplementation with a conjugated linoleic acid (CLA)-producing Bifidobacterium strain of human origin (B. breve NCIMB 702258) influenced the composition of bioactive fatty acids in host liver and adipose tissue in different animal species (18, 19) . Thus, in this study, we compared the effect of administering 2 different CLA-producing strains of the same species (ie, B. breve DPC 6330 and B. breve NCIMB 702258) on host fat distribution and composition. Furthermore, we performed a high-throughput pyrosequencebased assessment of the effect of oral administration of these B. breve strains on the diversity of the resident gut microbiota.
MATERIALS AND METHODS

Animals and treatment
Wild-type C57BL/6 male mice aged 7-8 wk were obtained from Charles River and housed under barrier-maintained conditions within the Biological Services Unit, University College Cork. All animal experiments were approved by the University College Cork Animal Ethics Committee, and experimental procedures were conducted under the appropriate license from the Irish Government. Mice were allowed to acclimatize for 1 wk before the start of the study and were fed ad libitum with Teklad Global rodent standard diet (#2018S; Harlan Laboratories) and allowed free access to water at all times. Mice were housed in groups of 4 per cage and kept in a controlled environment at 25°C under a 12-h-light/12-h-dark cycle. After 1 wk of acclimatization, the mice were divided into 3 groups (n = 8 per group): a control group fed with standard diet and placebo freeze-dried powder (15% wt:vol trehalose in dH 2 O), a group fed with standard diet and B. breve DPC 6330 (approximate daily dose of 10 9 microorganisms), and a group fed a standard diet and B. breve NCIMB 702258 (approximate daily dose of 10 9 microorganisms). The diet contained the following nutrient composition: crude protein (18.6%), carbohydrate (44.2%), fat (6.2%), crude fiber (3.5%), neutral detergent fiber (14.7%), and ash (5.3%). The fatty acids present in the diet included palmitic acid (16:0, 0.7%), stearic acid (18:0, 0.2%), oleic acid (18:1n29, 1.2%), linoleic acid (18:2n26, 3.1%), and linolenic acid (18:3n23, 0.3%). Body weight and food intake were assessed weekly. After 8 wk on the experimental diets, the animals were killed by decapitation. Liver, brain, fat pads (epididymal, perirenal, and mesenteric), gastrointestinal tract from stomach to anus, and cecal contents were removed, blotted dry on filter paper, weighed, and flash-frozen immediately in liquid nitrogen. All samples were stored at 280°C until processed. Blood samples were collected from starved animals and allowed to clot for 2 h at 4°C before centrifugation for 20 min at 2000 · g.
Preparation and administration of B. breve NCIMB 702258 and B. breve DPC 6330
We previously showed that B. breve NCIMB 702258 and B. breve DPC 6330 are efficient CLA producers, converting up to 65% and 76%, respectively, of linoleic acid to c9, t11 CLA when grown in 0.5 mg linoleic acid/mL in vitro (20, 21) . Rifampicinresistant variants of B. breve NCIMB 702258 and B. breve DPC 6330 were isolated by spread-plating ;10 9 colony forming units (CFU) from an overnight culture onto mMRS agar (Difco Laboratories) supplemented with 0.05% (wt:vol) L-cysteine hydrochloride (98% pure; Sigma Chemical Co) containing 500 lg rifampicin/mL (Sigma). After anaerobic incubation (anaerobic jars with Anaerocult A gas packs; Merck) at 37°C for 3 d, colonies were stocked in de Man, Rogosa, and Sharpe (MRS) broth containing 40% (vol:vol) glycerol and stored at 280°C. To confirm that the rifampicin-resistant variant was identical to the parent strain, pulse-field gel electrophoresis was used for molecular fingerprinting.
Before freeze-drying, B. breve NCIMB 702258 and B. breve DPC 6330 were grown in MRS by incubating overnight at 37°C under anaerobic conditions. The culture was washed twice in phosphate-buffered saline and resuspended at a concentration of ;2 · 10 10 cells/mL in 15% (wt:vol) trehalose (Sigma) in dH 2 O. One-milliliter aliquots were freeze-dried by using a 24-h program (freeze temperature, 240°C; condenser set point, 260; vacuum set point, 600 mTorr). Each mouse that received the bacterial strains consumed ;1 · 10 9 live microorganisms/d. This was achieved by resuspending appropriate quantities of freeze-dried powder in water, which mice consumed ad libitum. Mice that did not receive the bacterial strains received placebo freeze-dried powder [15% (wt:vol) trehalose in dH 2 O]. Water containing either the bacterial strains or placebo freeze-dried powder was the only water supply provided to the animals throughout the trial. Freeze-dried powders with the bacterial strains underwent continuous quality control of cell counts for the duration of the trial by plating serial dilutions on MRS agar supplemented with 100 lg mupirocin/mL (Oxoid) and 100 lg rifampicin/mL (Sigma) and incubating plates anaerobically for 72 h at 37°C.
Culture-dependent microbial analysis
Fresh fecal samples were taken from C57BL/6 mice every week for microbial analysis. Microbial analysis of the fecal samples involved enumeration of the B. breve strains by plating serial dilutions on MRS agar supplemented with 100 lg mupirocin (Oxoid)/mL, 100 lg rifampicin/mL (Sigma), and 50 U nystatin/mL (Sigma). Agar plates were incubated anaerobically for 72 h at 37°C. In addition, proximal colonic contents were sampled at the time the mice were killed for enumeration of the administered B. breve strains.
Lipid extraction and fatty acid analysis
Lipids were extracted with chloroform:methanol (2:1, vol:vol; Fisher Scientific) according to the method of Folch et al (22) . Fatty acid methyl esters (FAMEs) were prepared by using first 10 mL 0.5 N NaOH (Sigma) in methanol for 10 min at 90°C followed by 10 mL 14% BF 3 in methanol (Sigma) for 10 min at 90°C (23) . FAMEs were recovered with hexane (Fisher Scientific). Before gas-liquid chromatographic analysis, samples were dried over 0.5 g anhydrous sodium sulfate (Sigma) for 1 h and stored at 220°C. FAMEs were separated by gas-liquid chromatography (Varian 3800; Varian) fitted with a flameionization detector by using a Chrompack CP Sil 88 column (Chrompack; 100 m · 0.25 mm internal diameter, 0.20-lm film thickness) and helium as carrier gas. The column oven was programmed to be held initially at 80°C for 8 min and then increased by 8.5°C/min to a final column temperature of 200°C. The injection volume used was 0.6 lL, with automatic sample injection on a SPI 1093 splitless on-column temperature-programmable injector. Peaks were integrated by using the Varian Star Chromatography Workstation version 6.0 software, and peaks were identified by comparison of retention times with pure FAME standards (Nu-Chek Prep). The percentage of individual fatty acids was calculated according to the peak areas relative to the total area (total fatty acids were set at 100%). All fatty acid results are shown as means 6 SEMs in g/100 g FAMEs.
SCFA analysis
Approximately 100 mg cecal content was vortex-mixed with 1.0 mL Milli-Q water and, after standing for 10 min at room temperature, centrifuged at 10,000 · g for 5 min to pellet bacteria and other solids. The supernatant fluid was collected, 3.0 mmol 2-ethylbutyric acid/L (Sigma) was added as internal standard, and samples were filtered before being transferred to clean vials. Standard solutions containing 10.0 mmol/L,
.0 mmol/L, and 0.5 mmol/L of acetic acid, propionic acid, isobutyric acid, and butyric acid (Sigma), respectively, were used for calibration. The concentration of SCFAs was measured by using a Varian 3500 GC flame-ionization system, fitted with a Nukol-FFAP column (30 m · 0.32 mm · 0.25 lm; Sigma). Helium was used as the carrier gas at a flow rate of 1.3 mL/min. The initial oven temperature was 100°C for 0.5 min, raised to 180°C at 8°C/min and held for 1 min, then increased to 200°C at 20°C/min, and finally held at 200°C for 5 min. The temperature of the detector and the injector were set at 250°C and 240°C, respectively. Peaks were integrated by using the Varian Star Chromatography Workstation version 6.0 software. Standards were included in each run to maintain the calibration.
Measurement of triglycerides in liver
Liver lipids were extracted and purified according to the method of Folch et al (22) . After being mixed thoroughly, the samples were dried under nitrogen and resolubilized in 5% (vol: vol) Triton X-100 in dH 2 O. The concentration of triglycerides was measured by using a commercial kit (EnzyChrom Triglyceride Assay kit; BioAssay Systems). The results were normalized to the weight of the samples.
Measurements of serum variables
Serum variables were measured with commercial kits. Serum glucose was measured by using a QuantiChrom glucose assay kit (BioAssay Systems), serum insulin was measured by using the Ultra Sensitive Mouse ELISA kit (Crystal Chem Inc), serum leptin was measured by using the Mouse Leptin ELISA kit (Crystal Chem Inc), and serum triglycerides were measured by using EnzyChrom Triglyceride Assay kit (BioAssay Systems).
Culture-independent microbial analysis
For analysis of the microbial community composition of the cecal contents, total DNA was extracted from the cecal contents of all mice by using the QIAamp DNA stool mini kit according to the manufacturer's instructions (Qiagen) coupled with an initial bead-beating step. Universal 16s rRNA primers, designed to amplify from highly conserved regions corresponding to those flanking the V4 region, ie, the forward primer F1 (5#-AYTG-GGYDTAAAGNG) and a combination of 4 reverse primers-R1 (5#-TACCRGGGTHTCTAATCC), R2 (5#-TACCAGAG-TATCTAATTC), R3 (5#-CTACDSRGGTMTCTAATC) and R4 (5#-TACNVGGGTATCTAATC) (RDP's Pyrosequencing Pipeline: http://pyro.cme.msu.edu/pyro/help.jsp)-were used for Taq-based polymerase chain reaction amplification. Sequencing was performed on a Roche 454 GS-FLX by using Titanium chemistry with the Teagasc 454 Sequencing Platform. Resulting raw sequences reads were quality trimmed as previously described (24). Trimmed FASTA sequences were then BLASTed (25) against a previously published 16S-specific database (26) by using default parameters. The resulting BLAST output was parsed by using MEGAN (27) . MEGAN assigns reads to NCBI taxonomies by using the Lowest Common Ancestor algorithm. Bit scores were used from within MEGAN for filtering the results before tree construction and summarization. A bit score of 86 was selected as previously used for 16S ribosomal sequence data (26) . Phylum and family counts for each subject were extracted from MEGAN. Clustering and alpha diversities were generated with the MOTHUR software package (28) . Beta diversities and principal coordinate analysis (PCoA) of sequence reads were calculated by using the Qiime suite of tools (29) .
Statistical analysis
Results in the text, tables, and figures are presented as means 6 SEMs (per group). To assess whether differences between treatment groups were significant, data were analyzed by using one-factor ANOVA followed by post hoc Tukey's multiple comparisons test with the use of GraphPad Prism version 4.0 for Windows (GraphPad Software). Compositional data were statistically analyzed by using Minitab release 15.1.1.0 (www.minitab.com). The nonparametric Kruskal-Wallis test was used to estimate the relations between different groups. Statistical significances were accepted at P , 0.05, and trends for statistically significant differences were recognized at P , 0.10. At sacrifice, B. breve DPC 6330 and B. breve NCIMB 702258 were detected in the large intestine at 7 · 10 5 CFU/g content and 1 · 10 6 CFU/g content, respectively, in the mice administered the strains.
Dietary supplementation with B. breve NCIMB 702258, but not B. breve DPC 6330, increases visceral host fat storage
The weight of visceral body fat-the sum of epididymal, mesenteric, and perirenal fat pads-was significantly higher in mice fed B. breve NCIMB 702258 than in unsupplemented mice (1.71 6 0.13 and 1.20 6 0.10 g; P , 0.05; Table 1 ). This increase in visceral fat mass correlated with a tendency for greater circulating leptin in mice supplemented with B. breve NCIMB 702258 than in unsupplemented controls (5.2 6 0.9 and 2.4 6 0.7 ng/mL; P = 0.06; Table 2 ). No significant difference in body mass was found between the groups over the 8-wk feeding period (Table 1) . No effect on liver mass or liver triglycerides was observed after administration of B. breve NCIMB 702258. In contrast, administration of B. breve DPC 6330 was associated with a higher concentration of liver triglycerides than was no supplementation (P , 0.05; Table 1 ). Neither of the administered B. breve strains affected the concentrations of circulating insulin, glucose, or triglycerides relative to no supplementation (Table 2 ). In addition, no difference in food intake was observed between the groups (data not shown).
Higher gut concentrations of SCFAs after administration of B. breve DPC 6330 and B. breve NCIMB 702258
Analysis of cecal SCFAs, the major fermentation end products and source of energy for the host, showed that propionate was significantly higher in mice fed B. breve DPC 6330 and B. breve NCIMB 702258 than in nonsupplemented mice (P , 0.05; Table 3 ). Higher concentrations of isobutyrate were also observed in mice supplemented with B. breve NCIMB 702258 than in unsupplemented controls (P , 0.05; Table 3 ). In addition, the mean total SCFA concentration (acetate, propionate, butyrate, and isobutyrate) detected in the cecal contents was 24% higher in mice fed B. breve DPC 6330 than in unsupplemented controls (P = 0.07; Table 3 ).
Contrasting effects on host tissue fatty acid composition of dietary supplementation with B. breve DPC 6330 and B. breve NCIMB 702258
To investigate the effects of dietary supplementation with B. breve DPC 6330 and B. breve NCIMB 702258 on the fatty acid composition of host tissues, fatty acid profiling was performed on brain, epididymal adipose tissue, and liver. Significant differences in tissue fatty acid composition were observed after supplementation with the B. breve strains (Tables 4-6 ). Mice fed B. breve NCIMB 702258 had significantly higher stearic acid (18:0), arachidonic acid (ARA; 20:4n26), and DHA (22:6n23) contents in the brain than did the unsupplemented mice (P , 0.05) and the mice supplemented with B. breve DPC All values are means 6 SEMs; n = 8 mice per group. Values in the same row with different superscript letters are significantly different, P , 0.05 (ANOVA followed by post hoc Tukey's multiple comparisons tests).
2 Includes epididymal, perirenal, and mesenteric fat pads. All values are means 6 SEMs; n = 8 mice per group. No significant differences were observed. Blood samples were collected after the mice were starved.
2 P = 0.06 (ANOVA followed by post hoc Tukey's multiple comparisons tests).
6330 (P , 0.05; Table 4 ), whereas dietary supplementation with B. breve DPC 6330 resulted in higher myristic acid (14:0) in the brain compared with both unsupplemented mice and mice supplemented with B. breve NCIMB 702258 (P , 0.05; Table 4 ). However, both groups of B. breve-supplemented mice had significantly lower palmitic acid (16:0), palmitoleic acid (16:1c9), and dihomo-c-linolenic acid (20:3n26) in the brain than did the unsupplemented controls (P , 0.05; Table 4 ).
Mice that received B. breve DPC 6330 had significantly higher myristic acid, palmitic acid, palmitoleic acid, and DHA in epididymal adipose tissue than did unsupplemented mice (P , 0.05; Table 5 ). In contrast, these fatty acids were not higher in the epididymal adipose tissue of the mice supplemented with B. breve NCIMB 702258. Mice that received B. breve DPC 6330 also had significantly lower oleic acid (18:1c9) in epididymal adipose tissue than did both the unsupplemented mice and mice supplemented with B. breve NCIMB 702258 (P , 0.05; Table 5 ). In contrast to a higher concentration of DHA in epididymal adipose tissue of mice fed B. breve DPC 6330, these mice had a lower concentration of DHA in liver than did unsupplemented mice (P , 0.05; Table   6 ). There was a tendency for higher concentrations (P = 0.06) of c9, t11 CLA in the livers of mice receiving B. breve NCIMB 702258 (0.031 6 0.006 g/100 g FAME) than in mice supplemented with B. breve DPC 6330 (0.015 6 0.007 g/100 g FAME) and in unsupplemented controls (0.013 6 0.006 g/100 g FAME).
Contrasting effects on gut microbiota composition of dietary supplementation with B. breve NCIMB 702258 and B. breve DPC 6330
At the end of the 8-wk study, the microbial composition of the gut microbiota of individual mice was elucidated through high throughput pyrosequencing (Roche-454 Titanium) of 16S rRNA (V4) amplicons generated from DNA extracted from the cecal content. A total of 103,711 reads were sequenced, averaging at 4509 reads per animal. Species-richness, coverage, and diversity estimations were calculated for each data set (see Supplementary  Table 1 under "Supplemental data" in the online issue). At the 97% similarity level, the Shannon index-a metric for community diversity-showed a high level of overall biodiversity Unsupplemented mice g/100 g FAME g/100 g FAME g/100 g FAME Myristic acid, 14: All values are means 6 SEMs; n = 8 mice per group. Values in the same row with different superscript letters are significantly different, P , 0.05 (ANOVA followed by post hoc Tukey's multiple comparisons tests). FAME, fatty acid methyl ester; ND, not detected. within all samples with values exceeding 5.1. The Good's coverage at the 97% similarity level ranged between 88% and 95% for all the data sets. Chao1 richness also indicated a sufficient level of overall diversity (see Supplementary Table 1 under "Supplemental data" in the online issue). Rarefaction curves for each data set were parallel or approaching parallel with the x axis, which indicated that the total bacterial diversity present within these was well represented and that additional sampling would yield a limited increase in species richness (see Supplementary Figure 1 under "Supplemental data" in the online issue).
In agreement with previous work (2-4), taxonomy-based analysis showed that, at the phylum level, the mouse gut microbiota was dominated by Firmicutes and Bacteroidetes (together harboring on average 94% of sequences; Figure 1) . At the family level, the most dominant groups were Bacteroidaceae, Clostridiaceae, Eubacteriaceae, and Lactobacillaceae ( Figure 2) .
A comparison of the composition of the microbiota of mice supplemented with B. breve NCIMB 702258, mice supplemented with B. breve DPC 6330, and unsupplemented mice showed that administration of these strains altered the composition of the gut microbiota differently at the phylum, family, and genus levels. There was a tendency for a reduction in the Firmicutes population from 74% in the unsupplemented mice to 68% in the mice supplemented with B. breve NCIMB 702258 and 67% in mice supplemented with B. breve DPC 6330 (P = 0.08; Figure 1 ). All other phyla remained at relatively similar All values are means 6 SEMs; n = 8 mice per group. Values in the same row with different superscript letters are significantly different, P , 0.05 (ANOVA followed by post hoc Tukey's multiple comparisons tests). FAME, fatty acid methyl ester. All values are means 6 SEMs; n = 8 mice per group. Values in the same row with different superscript letters are significantly different, P , 0.05 (ANOVA followed by post hoc Tukey's multiple comparisons tests). FAME, fatty acid methyl ester.
proportions across the groups. At the family level, administration of both B. breve DPC 6330 and B. breve NCIMB 702258 resulted in a significantly lower proportion of Lachnospiraceae than did no supplementation (P , 0.05; Figure 2) . Furthermore, Eubacteriaceae tended to be less abundant in the cecum of mice supplemented with B. breve DPC 6330 than in mice supplemented with B. breve NCIMB 702258 and unsupplemented controls (3%, 12%, and 13%, respectively; P = 0.06; Figure 2 ). Other observed differences at the family level included a tendency for an apparent enrichment in the Clostridiaceae population in mice supplemented with B. breve DPC 6330 (25%) than in mice supplemented with B. breve NCIMB 702258 (12%) and unsupplemented mice (18%; P = 0.08; Figure 2) . At the genus level, Eubacterium tended to be lower after dietary supplementation with B. breve DPC 6330 than after no supplementation or supplementation with B. breve NCIMB 702258 (P = 0.06; Figure 3) .
PCoA generated using unweighted UNIFRAC distances showed that mice clustered into relatively distinct groups based on whether they received B. breve DPC 6330, B. breve NCIMB 702258, or no supplementation (Figure 4) . Mice fed B. breve DPC 6330 clustered closely together and showed a clear separation from the unsupplemented mice and the mice supplemented with B. breve NCIMB 702258. This suggests that supplementation with B. breve DPC 6330 had a greater effect on the gut microbiota than did supplementation with B. breve NCIMB 702258. 
DISCUSSION
This study showed that the response of fatty acid metabolism to administration of bifidobacteria is strain-dependent and furthermore highlights the importance of strain-strain differences in modifying the gut microbiota composition of the host. Administration of B. breve NCIMB 702258 increased visceral fat mass and weight gain in C57BL/6 mice, whereas administration of B. breve DPC 6330 did not. In general, beneficial effects have been attributed to Bifidobacterium in connection with obesity and weight management, and some reports support the preventative role of bifidobacteria in promoting fat mass development and body weight gain (15, 16, 30) . However, other studies contradict the preventative role of Bifidobacterium in body weight gain (17, 31) and question the role of specific Bifidobacterium species in obesity and weight management (17) . Because the Bifidobacterium genus is complex, it is possible that certain bifidobacterial species, or even strains, as observed in the current study, promote fat mass storage and body weight more efficiently than others through diverse regulatory roles in fat absorption and distribution. Notably, strains of B. breve were previously shown to improve weight gain in very-low-birthweight infants (32) . However, it must be acknowledged that this study was limited to 2 strains of B. breve; therefore, further studies are required to draw conclusions about the role of specific Bifidobacterium species and strains in fat/energy absorption and their effect on weight gain in animal models of obesity and in humans.
Previous studies have shown that the gut microbiota affect the composition and quality of fat in the host as well as the quantity of fat (33) . We showed that manipulation of the gut microbiota by administering a single metabolically active strain, B. breve NCIMB 702258, to different animal species influenced the composition of bioactive fatty acids in host liver and adipose tissue (18) . In the current study, we compared the effect of B. breve NCIMB 702258 and B. breve DPC 6330 on fatty acid composition of different host tissues in mice. We observed that administration of these B. breve strains altered the fatty acid composition in distinct ways. Whereas administration of B. breve DPC 6330 had a greater influence on the fatty acid composition of epididymal adipose tissue, with higher palmitic acid, palmitoleic acid, and DHA, administration of B. breve NCIMB 702258 had a greater effect on the fatty acid composition of the brain. Intriguingly, mice supplemented with B. breve NCIMB 702258 had significantly higher concentrations of ARA and DHA in brain than did both mice supplemented with B. breve DPC 6330 and unsupplemented mice. This observation of increased ARA and DHA in the brain of mice administered B. breve NCIMB 702258 is consistent with our previous findings in a different model (19) . ARA and DHA play important roles in neurogenesis, neurotransmission, and protection against oxidative stress (34, 35) , and their concentrations in the brain influence cognitive processes such as learning and memory (36, 37) . The importance of these fatty acids in neurodevelopment has led to their supplementation in infant formula (38) . The current study supports our previous observations (18, 19) , and findings by others (39, 40) , in which manipulation of the gut microbiota altered the composition of fat in the host. Interactions between fatty acids and members of the gut microbiota might affect the biological roles of both, and such interactions may therefore result in physiologic consequences for the host.
The mechanism by which these ingested strains mediate the changes in fatty acid composition observed in the current study is unclear and remains to be elucidated. Possible explanations include modulations of fat-absorption processes in the small intestine and/or desaturase activities involved in the metabolism of fatty acids to the longer-chain unsaturated derivatives caused either directly by the strains administered or by alterations in the gut microbiota. Interestingly, a previous study in lactating goats showed that administration of a Lactobacillus plantarum strain resulted in changes in the fecal microbiota and modulated the milk fatty acid composition with a higher content of PUFAs (41) . Furthermore, a recent study by Hoppu et al (42) reported FIGURE 4 . Principal coordinate analysis using unweighted UniFrac distances in mice supplemented with Bifidobacterium breve DPC 6330 (n = 7) or B. breve NCIMB 702258 (n = 7) and in unsupplemented mice (n = 8). that dietary supplementation of lactating women with Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12, in combination with rapeseed oil, resulted in higher c-linolenic acid concentrations in breast milk than did fatty acid supplementation alone (42) .
The current study showed not only significant differences in the composition of the gut microbiota between mice fed or not fed B. breve, but also differences between mice fed different strains of B. breve. At the phylum level, the Firmicutes population tended to be more abundant in the cecum of mice supplemented with B. breve DPC 6330 and B. breve NCIMB 702258 than in unsupplemented mice. At the family level, the proportions of Eubacteriaceae were reduced in the animals receiving B. breve DPC 6330, but not in those receiving B. breve NCIMB 702258, compared with unsupplemented controls. In addition, administration of B. breve DPC 6330 led to an apparent enrichment in Clostridiaceae compared with the unsupplemented mice, whereas this enrichment was absent in mice supplemented with B. breve NCIMB 702258. Penicillium was found in the mice supplemented with B. breve NCIMB 702258; however, this genus is not considered to be a typical member of the gut microbiota, and factors contributing to its presence in the gut, as found in this instance, require further investigation. PCoA analysis showed that mice fed B. breve DPC 6330 had a more divergent clustering pattern and were separated from the unsupplemented mice and from mice fed B. breve NCIMB 702258. This suggests that supplementation with B. breve DPC 6330 has a greater effect on the composition of the murine gut microbiota than does supplementation with B. breve NCIMB 702258. Our observations suggest that administration of a single strain can play a role in determining the composition of gut bacterial populations in vivo and furthermore that strain-strain differences are important factors with respect to modulation of the gut microbial community. Although changing the intestinal microbiota may be more difficult in free-living individuals than in laboratory models, it is important to perform extensive microbiotarelated studies on bifidobacteria-associated probiotics in human trials, especially in groups in which shifts in the composition have been observed due to the state of physiology (ie, obesity and diabetes), particularly because an alteration of the gut microbiota at lower taxonomic levels is still likely to have important functional consequences for the host. Whereas it is acknowledged that pyrosequencing of the 16S rRNA genes, as undertaken in this study, did not provide quantitative population data, it did yield an overview of the effects of administration of these strains on the entire microbial population.
SCFAs (acetate, propionate, butyrate, and isobutyrate) are major products of the fermentation processes of the gut microbiota on nondigestible carbohydrates in the intestine. These fatty acids have recently attracted significant interest because of their positive effect on human gastrointestinal health and diseases, including colon cancer, gastrointestinal infections, and inflammatory bowel disease (43) (44) (45) (46) . SCFAs are also believed to be a driver of energy-sparing and are portrayed as a potential mechanism involved in the increase of fat mass storage in microbiota-bearing mice (3). The differences in stool SCFA concentrations between lean and obese people have been considerable. The mean total SCFA concentration in fecal samples of obese volunteers was shown to be .20% higher than in lean volunteers, with the highest increase observed for propionate, which was 41% higher in obese volunteers (6) . Administration of B. breve DPC 6330 and B. breve NCIMB 702258 led to an increase in propionate in the cecum that was 37% higher in mice supplemented with B. breve DPC 6330 and 30% higher in mice supplemented with B. breve NCIMB 702258 than in unsupplemented mice. Noteworthy, neither of these B. breve strains produce propionate in vitro, which suggests that administration of these strains may result in an increase in propionate-producing bacteria in the gastrointestinal tract. Well-known propionate producers belong to the genera Bacteroides spp., Prevotella spp., and Propionibacterium spp. (6, 47) . However, because many metabolic properties are shared between lower microbial taxa, it is difficult to link the capacity of producing specific SCFAs, such as propionate, to the phylogenetic information obtained in the current study (48) . Increases in propionate in the B. breve-fed mice could also be due to crossfeeding, in which one bacterial species metabolizes the fermentation products of another, thus producing a different end product, a common cooperation in a complex microbial community. Indeed, Bifidobacterium are known to produce lactate, ethanol, and succinate (49, 50) , all of which could be used as substrates for the production of propionate by other bacteria, such as Bacteroides spp., Propionibacterium spp., and Clostridium propionicum in a sequential fermentation, thus increasing the propionate concentration in the gut (47, 51) .
In conclusion, our results indicate that the effect of bifidobacteria on host fatty acid metabolism is dependent on the strain administered and that strain-strain differences are important factors that influence the modulation of the gut microbial community by ingested microorganisms. Additional studies are needed to draw conclusions about the role of specific Bifidobacterium species and strains in obesity and weight management.
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